Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Iradimed Corp before investing.

In this article, we go over a few key elements for understanding Iradimed Corp’s stock price such as:

• Iradimed Corp’s current stock price and volume
• Why Iradimed Corp’s stock price changed recently
• Upgrades and downgrades for IRMD from analysts
• IRMD’s stock price momentum as measured by its relative strength

About Iradimed Corp (IRMD)

Before we jump into Iradimed Corp’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.

Want to learn more about Iradimed Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Iradimed Corp.

Iradimed Corp’s Stock Price as of Market Close

As of September 10, 2024, 4:00 PM, CST, Iradimed Corp’s stock price was $46.85.

Iradimed Corp is up 4.11% from its previous closing price of $45.00.

During the last market session, Iradimed Corp’s stock traded between $44.65 and $45.27. Currently, there are 12.66 million shares of Iradimed Corp stock available for purchase.

Iradimed Corp’s price-earnings (P/E) ratio is currently at 30.8, which is low compared to the Advanced Medical Equipment & Technology industry median of 33.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Iradimed Corp Stock Price History

Iradimed Corp’s (IRMD) price is currently down 0.23% so far this month.

During the month of September, Iradimed Corp’s stock price has reached a high of $46.92 and a low of $44.58.

Over the last year, Iradimed Corp has hit prices as high as $50.93 and as low as $36.12. Year to date, Iradimed Corp’s stock is up 65.61%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Iradimed Corp Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 09, 2024, there were 0 analysts who downgraded Iradimed Corp’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Iradimed Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Iradimed Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Iradimed Corp’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Iradimed Corp (IRMD) by visiting AAII Stock Evaluator.

Relative Price Strength of Iradimed Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 09, 2024, Iradimed Corp has a weighted four-quarter relative price strength of -3.98%, which translates to a Momentum Score of 48 and is considered to be Average.

Want to learn more about how Iradimed Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Iradimed Corp Stock Price: Bottom Line

As of September 10, 2024, Iradimed Corp’s stock price is $46.85, which is up 4.11% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Iradimed Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.